|Last Price$19.95||Day Change (%)0.00%|
|Open Price$19.95||Day Change ($)0.00|
|Day Range19.90–19.95||52-Week Range10.98–21.40|
As of Fri 7/21/2017 5:33:00 PM | USD
NCI ( NCIT ) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of NCI , Inc.
Cancer Prevention Pharmaceuticals in Collaboration with the NCI and Vanderbilt University Medical Center Initiates Phase 2 Trial to Evaluate CPP-1X in Patients with High Risk of Gastric Cancer
NCI to Be Acquired by H.I.G. Capital, LLC
Shareholder Alert: Ademi & O’Reilly, LLP Investigates Whether NCI , Inc. Has Obtained a Fair Price in Its Sale to OceanFirst Financial Corp.
NCI agrees to be acquired by H.I.G. Capital for about $283 million in cash
NCI , INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of NCI , Inc. to H.I.G. Capital, LLC for $20.00 Per Share is Fair to Shareholders
Kite Highlights Durable Complete Remissions Up to 56+ Months in Patients with Chemorefractory Aggressive Non-Hodgkin Lymphoma (NHL) after Anti-CD19 CAR T-Cell Therapy at the National Cancer Institute
BlackRock Reports Second Quarter 2017 Diluted EPS of $5.22, or $5.24 as adjusted